MYCN upregulates the transsulfuration pathway to suppress the ferroptotic vulnerability in MYCN -amplified neuroblastoma

• Published in: Cell Stress 2022-02, Vol.6 (2), p.21-29
• Main Authors: Floros, Konstantinos V, Chawla, Ayesha T, Johnson-Berro, Mia O, Khatri, Rishabh, Stamatouli, Angeliki M, Boikos, Sosipatros A, Dozmorov, Mikhail G, Cowart, L Ashley, Faber, Anthony C
• Format: Article
• Language: English
• Subjects: cystathionine; cysteine; ferroptosis; methionine; MYCN-amplified neuroblastoma; Research Report; transsulfuration pathway
• ISSN: 2523-0204; 2523-0204
• DOI: 10.15698/cst2022.02.264

Ferroptosis is an iron-dependent, oxidative form of cell death that is countered mainly by glutathione peroxidase 4 (GPX4) and the production of glutathione (GSH), which is formed from cysteine. The identification of the cancers that may benefit from pharmacological ferroptotic induction is just emerging. We recently demonstrated that inducing ferroptosis genetically or pharmacologically in -amplified neuroblastoma (NB) is a novel and effective way to kill these cells. MYCN increases iron metabolism and subsequent hydroxyl radicals through increased expression of the transferrin receptor 1 (TfR1) and low levels of the ferroportin receptor. To counter increased hydroxyl radicals, MYCN binds to the promoter of (solute carrier family 3 member 2). SLC3A2 is a subunit of system Xc-, which is the cysteine-glutamate antiporter that exports glutamate and imports cystine. Cystine is converted to cysteine intracellularly. Here, we investigated other ways MYCN may increase cysteine levels. By performing metabolomics in a syngeneic NB cell line either expressing MYCN or GFP, we demonstrate that the transsulfuration pathway is activated by MYCN. Furthermore, we demonstrate that -amplified NB cell lines and tumors have higher levels of cystathionine beta-synthase (CBS), the rate-limiting enzyme in transsulfuration, which leads to higher levels of the thioether cystathionine ( -(2-amino-2-carboxyethyl)-l-homocysteine). In addition, -amplified NB tumors have high levels of methylthioadenosine phosphorylase (MTAP), an enzyme that helps salvage methionine following polyamine metabolism. MYCN directly binds to the promoter of . We propose that MYCN orchestrates both enhanced cystine uptake and enhanced activity of the transsulfuration pathway to counteract increased reactive oxygen species (ROS) from iron-induced Fenton reactions, ultimately contributing to a ferroptosis vulnerability in -amplified neuroblastoma.